IDEAYA Biosciences (IDYA) EBIT Growth (3y) (2021 - 2026)
IDEAYA Biosciences (IDYA) EBIT Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 6.70% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 8.36% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 89.72% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 44.54% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -26.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -18.82% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 44.34% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 81.27% |
| 10 | IDEAYA Biosciences | 3.50 Bn | 2.67 Bn | - | -55.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -55.21% |
| Mar 31, 2026 | -60.45% |
| Dec 31, 2025 | -52.93% |
| Sep 30, 2025 | 447.73% |
| Jun 30, 2025 | -58.04% |
| Mar 31, 2025 | -81.05% |
| Dec 31, 2024 | -98.72% |
| Sep 30, 2024 | -78.75% |
| Jun 30, 2024 | -80.44% |
| Mar 31, 2024 | -77.42% |
| Dec 31, 2023 | -99.49% |
| Sep 30, 2023 | -88.62% |
| Jun 30, 2023 | -37.47% |
| Mar 31, 2023 | -28.18% |
| Dec 31, 2022 | -32.69% |
| Sep 30, 2022 | 27.17% |
| Jun 30, 2022 | -26.05% |
| Mar 31, 2022 | -12.10% |
| Dec 31, 2021 | -26.23% |
| Sep 30, 2021 | 4.92% |